Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Deferred Tax Liability: 2017-2025

Historic Non-Current Deferred Tax Liability for Ascendis Pharma A (ASND) over the last 7 years, with Sep 2025 value amounting to $12.0 million.

  • Ascendis Pharma A's Non-Current Deferred Tax Liability rose 2100.56% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 2100.56%. This contributed to the annual value of $7.9 million for FY2024, which is 25.23% up from last year.
  • Ascendis Pharma A's Non-Current Deferred Tax Liability amounted to $12.0 million in Q3 2025, which was up 10.64% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Non-Current Deferred Tax Liability registered a high of $12.0 million during Q3 2025, and its lowest value of -$10.1 million during Q3 2023.
  • For the 3-year period, Ascendis Pharma A's Non-Current Deferred Tax Liability averaged around $2.8 million, with its median value being $6.3 million (2023).
  • Data for Ascendis Pharma A's Non-Current Deferred Tax Liability shows a peak YoY increase of 2,904.72% (in 2022) and a maximum YoY decrease of 1,895.76% (in 2022) over the last 5 years.
  • Ascendis Pharma A's Non-Current Deferred Tax Liability (Quarterly) stood at $6.0 million in 2021, then soared by 2,904.72% to $10.8 million in 2022, then plummeted by 192.93% to $6.3 million in 2023, then climbed by 23.64% to $7.8 million in 2024, then spiked by 2,100.56% to $12.0 million in 2025.
  • Its Non-Current Deferred Tax Liability was $12.0 million in Q3 2025, compared to $10.9 million in Q2 2025 and $8.1 million in Q1 2025.